Modulation of Hepatic Fibrosis by c-Jun-N-Terminal Kinase Inhibition
Open Access
- 1 January 2010
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 138 (1), 347-359
- https://doi.org/10.1053/j.gastro.2009.09.015
Abstract
No abstract availableKeywords
Funding Information
- American Liver Foundation
This publication has 43 references indexed in Scilit:
- Effects of losartan on hepatic expression of nonphagocytic NADPH oxidase and fibrogenic genes in patients with chronic hepatitis CAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2009
- c-Jun N-terminal Kinase-1 From Hematopoietic Cells Mediates Progression From Hepatic Steatosis to Steatohepatitis and Fibrosis in MiceGastroenterology, 2009
- Differential effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance†Hepatology, 2008
- Mechanisms of Hepatic FibrogenesisGastroenterology, 2008
- Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the LiverPhysiological Reviews, 2008
- Critical role of c-jun (NH2) terminal kinase in paracetamol- induced acute liver failureGut, 2007
- Uses for JNK: the Many and Varied Substrates of the c-Jun N-Terminal KinasesMicrobiology and Molecular Biology Reviews, 2006
- Loss of hepatic NF-κB activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activationProceedings of the National Academy of Sciences, 2006
- Tumor Necrosis Factor-induced Toxic Liver Injury Results from JNK2-dependent Activation of Caspase-8 and the Mitochondrial Death PathwayJournal of Biological Chemistry, 2006
- A dual reporter gene transgenic mouse demonstrates heterogeneity in hepatic fibrogenic cell populationsHepatology, 2004